CLINICAL TRIALS PROFILE FOR VESICARE
✉ Email this page to a colleague
All Clinical Trials for VESICARE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00333112 ↗ | A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. | Completed | Astellas Pharma Inc | Phase 4 | 2006-05-01 | A study to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men. |
NCT00368706 ↗ | A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients | Completed | Astellas Pharma Inc | Phase 3 | 2006-09-01 | To evaluate the efficacy and safety of solifenacin succinate (Vesicare) 5mg OD in subjects with overactive bladder compared to tolterodine wmg, bid |
NCT00431041 ↗ | Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) | Completed | Astellas Pharma Canada, Inc. | Phase 4 | 2006-12-01 | The purpose of this study is to compare the safety and efficacy of solifenacin with oxybutynin immediate-release (IR) for the treatment of overactive bladder (OAB). |
NCT00431041 ↗ | Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) | Completed | Astellas Pharma Inc | Phase 4 | 2006-12-01 | The purpose of this study is to compare the safety and efficacy of solifenacin with oxybutynin immediate-release (IR) for the treatment of overactive bladder (OAB). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VESICARE
Condition Name
Clinical Trial Locations for VESICARE
Trials by Country
Clinical Trial Progress for VESICARE
Clinical Trial Phase
Clinical Trial Sponsors for VESICARE
Sponsor Name